The latest price target for Outset Medical (NASDAQ:OM) was reported by RBC Capital on August 8, 2024. The analyst firm set a price target for $3.00 expecting OM to rise to within 12 months (a possible 147.93% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Outset Medical (NASDAQ:OM) was provided by RBC Capital, and Outset Medical downgraded their sector perform rating.

The last upgrade for Outset Medical Inc happened on June 21, 2024 when RBC Capital raised their price target to $6. RBC Capital previously had a sector perform for Outset Medical Inc.

The last downgrade for Outset Medical Inc happened on August 8, 2024 when RBC Capital changed their price target from $6 to $3 for Outset Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Outset Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Outset Medical was filed on August 8, 2024 so you should expect the next rating to be made available sometime around August 8, 2025.

While ratings are subjective and will change, the latest Outset Medical (OM) rating was a downgraded with a price target of $6.00 to $3.00. The current price Outset Medical (OM) is trading at is $1.21, which is out of the analyst’s predicted range.